Brief Reports
Copyright ©The Author(s) 2000.
World J Gastroenterol. Oct 15, 2000; 6(5): 747-749
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.747
Table 3 Inhibition of subcutaneous HR8348 adenocarcinoma growth by ASODN
GroupDiameter of tumor (cm)Rate of tumorigenicity (%)
Control1.00 ± 0.08100 (10/10)
Liposome-RC150.95 ± 0.07100 (10/10)
Liposome-AEGFR0.8020 (2/10)